Torsion dystonia is one of the most common and least well understood of movement disorders in humans. Affected individuals manifest contracted, twisting postures due to abnormal neurotransmission of the basal ganglia. This Program is directed towards elucidation of neuronal dysfunction in the early onset form of dystonia, which commences in childhood and can be completely disabling. The DYTl gene responsible for this condition is inherited in an autosomal dominant manner with low penetrance and has been recently cloned by our group. Most cases of this disease are caused by loss of a glutamic acid residue in the carboxy terminus of a novel ATP- binding protein termed torsinA. This gene is expressed selectively and at high levels in dopaminergic neurons in the substantia nigra. TorsinA defines a new gene family with distant relationship to the heat shock/Clp proteins. Our hypothesis is that defects in this protein underlie susceptibility which can lead to diminished release of dopamine into the striatum and, in turn, to altered modeling of neuronal circuitry in the basal ganglia during childhood development. The resulting imbalance in neurotransmission would then affect processing of motor information in this critical region of the brain. Studies are designed to elucidate the role of members of the torsin gene family in this and other forms of dystonia, and to identify other genes which may affect penetrance by linkage and mutational analysis. Brain tissue from human controls and affected individuals, as well as transgenic knock-in mice, will be examined by immunocytochemistry and in situ hybridization to elucidate changes in the distribution and density of proteins involved in neurotransmission, including D1 and D2 receptors. The transgenic mice will also be evaluated for alterations in the development of neuronal connections in the basal ganglia, in behavior and in response to stress. The intracellular distribution of torsinA and the functional effects of the mutant protein will be assessed in cultured dopaminergic neurons and model neural system using immunocytochemistry and a helper virus-free amplicon vector delivery of normal and mutant genes. Cells will be evaluated for functions related to other members of the heat shock/Clp family, including response to heat shock, uptake and release of dopamine, and mitochondrial function. These studies capitalize on the recent identification of the DYTl gene to understand the molecular etiology of early onset torsion dystonia, to elucidate developmental and stress- related plasticity in the basal ganglia, and to provide insights into therapeutic intervention. Given the apparent involvement of dopaminergic neurons in dystonia and Parkinson's disease, these studies should also provide insight into the latter.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
1P01NS037409-01A1
Application #
2728659
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Spinella, Giovanna M
Project Start
1999-01-15
Project End
2002-12-31
Budget Start
1999-01-15
Budget End
1999-12-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Waugh, Jeff L; Kuster, John K; Levenstein, Jacob M et al. (2016) Thalamic Volume Is Reduced in Cervical and Laryngeal Dystonias. PLoS One 11:e0155302
Sundermann, Erin Elizabeth; Wang, Cuiling; Katz, Mindy et al. (2016) Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein ?4 on memory decline in older adults. Neurobiol Aging 41:200.e7-200.e12
DeAndrade, Mark P; Trongnetrpunya, Amy; Yokoi, Fumiaki et al. (2016) Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia. Mov Disord 31:1633-1639
de Carvalho Aguiar, Patricia; Borges, Vanderci; Ferraz, Henrique Ballalai et al. (2015) Novel compound heterozygous mutations in PRKRA cause pure dystonia. Mov Disord 30:877-8
Alcalay, Roy N; Mejia-Santana, Helen; Mirelman, Anat et al. (2015) Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease. Parkinsonism Relat Disord 21:106-10
Saunders-Pullman, Rachel; Alcalay, Roy N; Mirelman, Anat et al. (2015) REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Mov Disord 30:1834-9
Gupte, Manisha; Alcalay, Roy N; Mejia-Santana, Helen et al. (2015) Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relatives. J Genet Couns 24:238-46
Mirelman, Anat; Alcalay, Roy N; Saunders-Pullman, Rachel et al. (2015) Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Mov Disord 30:981-6
Yokoi, Fumiaki; Dang, Mai T; Liu, Jun et al. (2015) Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ?GAG heterozygous knock-in mice. Behav Brain Res 279:202-10
Yokoi, Fumiaki; Chen, Huan-Xin; Dang, Mai Tu et al. (2015) Behavioral and electrophysiological characterization of Dyt1 heterozygous knockout mice. PLoS One 10:e0120916

Showing the most recent 10 out of 82 publications